Oladoctor – online healthcare marketplace in Spain

Medicamentos de Roche Registration Gmbh en Spain

Filters

Clear filters

Filter by letter

All

ALECENSA 150 mg HARD CAPSULES

Dosage form: CAPSULE, 150 mg

Active substance: alectinib

Manufacturer: Roche Registration Gmbh

Prescription required

AVASTIN 25 mg/mL concentrate for infusion solution

Dosage form: INJECTABLE PERFUSION, 25 mg

Active substance: bevacizumab

Manufacturer: Roche Registration Gmbh

Prescription required

AVASTIN 25 mg/mL concentrate for infusion solution

Dosage form: INJECTABLE PERFUSION, 25 mg

Active substance: bevacizumab

Manufacturer: Roche Registration Gmbh

Prescription required

CELLCEPT 1 g/5 ml POWDER FOR ORAL SUSPENSION

Dosage form: ORAL SOLUTION/SUSPENSION, Unknown

Active substance: mycophenolic acid

Manufacturer: Roche Registration Gmbh

Prescription required

CELLCEPT 250 mg CAPSULES

Dosage form: CAPSULE, 250 mg

Active substance: mycophenolic acid

Manufacturer: Roche Registration Gmbh

Prescription required

CELLCEPT 500 MG FILM-COATED TABLETS

Dosage form: TABLET, 500 mg

Active substance: mycophenolic acid

Manufacturer: Roche Registration Gmbh

Prescription required

ENSPRYNG 120 mg READY-TO-USE INJECTION SOLUTION IN PRE-FILLED SYRINGE

Dosage form: INJECTABLE, 120 mg

Active substance: satralizumab

Manufacturer: Roche Registration Gmbh

Prescription required

ERIVEDGE 150 mg HARD CAPSULES

Dosage form: CAPSULE, 150 mg

Active substance: vismodegib

Manufacturer: Roche Registration Gmbh

Prescription required

ESBRIET 267 mg HARD CAPSULES

Dosage form: CAPSULE, 267 mg pirfenidone

Active substance: pirfenidone

Manufacturer: Roche Registration Gmbh

Prescription required

FUZEON 90 mg/ml POWDER AND SOLVENT FOR INJECTABLE SOLUTION

Dosage form: INJECTABLE, 90 mg

Active substance: enfuvirtide

Manufacturer: Roche Registration Gmbh

Prescription required

GAZYVARO 1000 MG CONCENTRATE FOR INFUSION SOLUTION

Dosage form: INJECTABLE INFUSION, 1000

Active substance: obinutuzumab

Manufacturer: Roche Registration Gmbh

Prescription required

HEMLIBRA 150 mg/mL Injectable Solution

Dosage form: INJECTABLE, 150 mg/ml

Active substance: emicizumab

Manufacturer: Roche Registration Gmbh

Prescription required

HEMLIBRA 30 mg/mL Injectable Solution

Dosage form: INJECTABLE, 30 mg/ml

Active substance: emicizumab

Manufacturer: Roche Registration Gmbh

Prescription required

HERCEPTIN 150 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION

Dosage form: INJECTABLE INFUSION, Unknown

Active substance: trastuzumab

Manufacturer: Roche Registration Gmbh

Prescription required

ITOVEBI 3 mg FILM-COATED TABLETS

Dosage form: TABLET, 3 mg

Manufacturer: Roche Registration Gmbh

Prescription required

ITOVEBI 9 mg FILM-COATED TABLETS

Dosage form: TABLET, 9 mg

Manufacturer: Roche Registration Gmbh

Prescription required

KADCYLA 100 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION

Dosage form: INJECTABLE PERFUSION, 100 mg

Active substance: trastuzumab emtansine

Manufacturer: Roche Registration Gmbh

Prescription required

KADCYLA 160 mg POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION

Dosage form: INJECTABLE PERFUSION, 160 mg

Active substance: trastuzumab emtansine

Manufacturer: Roche Registration Gmbh

Prescription required

LUNSUMIO 1 mg CONCENTRATE FOR INFUSION SOLUTION

Dosage form: INJECTABLE PERFUSION, 1 mg/mL

Active substance: mosunetuzumab

Manufacturer: Roche Registration Gmbh

Prescription required

LUNSUMIO 30 mg CONCENTRATE FOR INFUSION SOLUTION

Dosage form: INJECTABLE INFUSION, 1 mg/mL

Active substance: mosunetuzumab

Manufacturer: Roche Registration Gmbh

Prescription required

MABTHERA 100 mg CONCENTRATE FOR INFUSION SOLUTION

Dosage form: INJECTABLE, 100 mg

Active substance: rituximab

Manufacturer: Roche Registration Gmbh

Prescription required

MABTHERA 1400 mg SOLUTION FOR SUBCUTANEOUS INJECTION

Dosage form: INJECTABLE, 1400 mg

Active substance: rituximab

Manufacturer: Roche Registration Gmbh

Prescription required

MABTHERA 500 MG CONCENTRATE FOR INFUSION SOLUTION

Dosage form: INJECTABLE

Active substance: rituximab

Manufacturer: Roche Registration Gmbh

Prescription required

NEORECORMON 10000 IU PRE-FILLED SYRINGE SOLUTION FOR INJECTION

Dosage form: INJECTABLE, 10,000 IU

Active substance: erythropoietin

Manufacturer: Roche Registration Gmbh

Prescription required

NEORECORMON 2000 IU PRE-FILLED SYRINGE SOLUTION FOR INJECTION

Dosage form: INJECTABLE, 2000 IU

Active substance: erythropoietin

Manufacturer: Roche Registration Gmbh

Prescription required

NEORECORMON 20000 IU PRE-FILLED SYRINGE SOLUTION FOR INJECTION

Dosage form: INJECTABLE, 2000 kIU

Active substance: erythropoietin

Manufacturer: Roche Registration Gmbh

Prescription required

OCREVUS 300 mg concentrate for infusion solution

Dosage form: INJECTABLE PERFUSION, 300 mg

Active substance: ocrelizumab

Manufacturer: Roche Registration Gmbh

Prescription required

PERJETA 420 mg CONCENTRATE FOR SOLUTION FOR INFUSION

Dosage form: INJECTABLE PERFUSION, 420 mg

Active substance: pertuzumab

Manufacturer: Roche Registration Gmbh

Prescription required

PHESGO 1200 mg/600 mg Injectable Solution

Dosage form: INJECTABLE, 1200 mg / 600 mg

Active substance: pertuzumab and trastuzumab

Manufacturer: Roche Registration Gmbh

Prescription required

PHESGO 600 MG/600 MG INJECTABLE SOLUTION

Dosage form: INJECTABLE, 1200 - REVIEW mg

Active substance: pertuzumab and trastuzumab

Manufacturer: Roche Registration Gmbh

Prescription required

ROACTEMRA 162 mg Injectable Solution in Pre-filled Syringe

Dosage form: INJECTABLE, 162 mg

Active substance: tocilizumab

Manufacturer: Roche Registration Gmbh

Prescription required

ROACTEMRA 20 mg/ml CONCENTRATE FOR INFUSION SOLUTION

Dosage form: INJECTABLE, 20 mg/ml

Active substance: tocilizumab

Manufacturer: Roche Registration Gmbh

Prescription required

ROACTEMRA 20 mg/ml CONCENTRATE FOR INFUSION SOLUTION

Dosage form: INJECTABLE, 20 mg/ml

Active substance: tocilizumab

Manufacturer: Roche Registration Gmbh

Prescription required

TAMIFLU 30 mg HARD CAPSULES

Dosage form: CAPSULE, 30 mg

Active substance: oseltamivir

Manufacturer: Roche Registration Gmbh

Prescription required

TAMIFLU 45 mg HARD CAPSULES

Dosage form: CAPSULE, 45 mg

Active substance: oseltamivir

Manufacturer: Roche Registration Gmbh

Prescription required

TAMIFLU 6 mg/ml ORAL SUSPENSION POWDER

Dosage form: ORAL SOLUTION/SUSPENSION, 6 mg oseltamivir/ml

Active substance: oseltamivir

Manufacturer: Roche Registration Gmbh

Prescription required

VABYSMO 120 mg/mL Injectable Solution

Dosage form: INJECTABLE, 120 mg/mL

Active substance: faricimab

Manufacturer: Roche Registration Gmbh

Prescription required

VABYSMO 120 mg/mL solution for injection in pre-filled syringe

Dosage form: INJECTABLE, 120 mg/ml

Active substance: faricimab

Manufacturer: Roche Registration Gmbh

Prescription required

ZELBORAF 240 mg FILM-COATED TABLETS

Dosage form: TABLET, 240 mg vemurafenib

Active substance: vemurafenib

Manufacturer: Roche Registration Gmbh

Prescription required

Medicamentos de Roche Registration Gmbh en Spain

Stay informed about Oladoctor